Recruiting
Phase 1
Phase 2

Promising ROd-cone DYstrophy Gene TherapY

Sponsor:

SparingVision

Code:

NCT05748873

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SPVN06

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information